Tang, et al, "Ivermectin, a potential anticancer drug derived from an antiparasitic drug", Pharmacological Research, vol 163 (January 2021), via ScienceDirect.com
OK, here I go again... "excuse my cynicsim, but"... is this, perhaps, another reason why we're not supposed to hear much about ivermectin? I can't reproduce it here, of course, for copyright reasons, but do check it out. At the very least, read the "highlights" of the research.
Will ivermectin "quickly enter clinical trials for the treatment of tumours"?